InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Explore the full record of transactions filed by Leonard Frank X, Directeur du Développement. Officer active across 1 companies, notably NovoCure Ltd. In total, 8 filings have been published. Total volume traded: €353k. The latest transaction was disclosed on 8 March 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€48,001744 shares@ €64.51720.0033% mcap12.3% of flow
Ordinary Shares
SEC:0001645113-22-000029:0·
017,371 shares0
Ordinary Shares
SEC:0001645113-22-000014:0·
€62,851540 shares@ €116.39130.0043% mcap36.9% of flow
Ordinary Shares
SEC:0001645113-21-000109·
€62,851540 shares@ €116.39130.0043% mcap16.2% of flow
Ordinary Shares
SEC:0001645113-21-000109:0·
€89,692713 shares@ €125.79570.0062% mcap52.6% of flow
Ordinary Shares
SEC:0001645113-21-000098·
€89,692713 shares@ €125.79570.0062% mcap23.1% of flow
Ordinary Shares
SEC:0001645113-21-000098:0·
€17,858154 shares@ €115.96410.0012% mcap10.5% of flow
Ordinary Shares
SEC:0001645113-21-000088·
€17,858154 shares@ €115.96410.0012% mcap4.6% of flow
Ordinary Shares
SEC:0001645113-21-000088:0·
8 of 8 declarations
About Leonard Frank X
Frank X. Leonard is the Chief Development Officer at NovoCure Ltd. He is responsible for leading the company's development initiatives, focusing on innovation and product expansion. His expertise is crucial for NovoCure's growth strategy.
